gama pharmed solutions limited
gama pharmed solutions limited Company Information
Company Number
08203789
Website
-Registered Address
c/o flb accountants llp, 1010 eskdale road, wokingham, RG41 5TS
Industry
Other human health activities
Telephone
-
Next Accounts Due
December 2024
Group Structure
View All
Directors
Joubert Gama11 Years
Shareholders
joubert gama 100%
gama pharmed solutions limited Estimated Valuation
Pomanda estimates the enterprise value of GAMA PHARMED SOLUTIONS LIMITED at £348.5k based on a Turnover of £1.1m and 0.33x industry multiple (adjusted for size and gross margin).
gama pharmed solutions limited Estimated Valuation
Pomanda estimates the enterprise value of GAMA PHARMED SOLUTIONS LIMITED at £113.9k based on an EBITDA of £37.5k and a 3.04x industry multiple (adjusted for size and gross margin).
gama pharmed solutions limited Estimated Valuation
Pomanda estimates the enterprise value of GAMA PHARMED SOLUTIONS LIMITED at £936.3k based on Net Assets of £403.2k and 2.32x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Gama Pharmed Solutions Limited Overview
Gama Pharmed Solutions Limited is a live company located in wokingham, RG41 5TS with a Companies House number of 08203789. It operates in the other human health activities sector, SIC Code 86900. Founded in September 2012, it's largest shareholder is joubert gama with a 100% stake. Gama Pharmed Solutions Limited is a established, small sized company, Pomanda has estimated its turnover at £1.1m with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Gama Pharmed Solutions Limited Health Check
Pomanda's financial health check has awarded Gama Pharmed Solutions Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs
3 Strong
1 Regular
6 Weak
Size
annual sales of £1.1m, make it larger than the average company (£720.8k)
- Gama Pharmed Solutions Limited
£720.8k - Industry AVG
Growth
3 year (CAGR) sales growth of 3%, show it is growing at a slower rate (5.3%)
- Gama Pharmed Solutions Limited
5.3% - Industry AVG
Production
with a gross margin of 20.5%, this company has a higher cost of product (35.9%)
- Gama Pharmed Solutions Limited
35.9% - Industry AVG
Profitability
an operating margin of 3.6% make it less profitable than the average company (6%)
- Gama Pharmed Solutions Limited
6% - Industry AVG
Employees
with 1 employees, this is below the industry average (19)
1 - Gama Pharmed Solutions Limited
19 - Industry AVG
Pay Structure
on an average salary of £24.6k, the company has an equivalent pay structure (£24.6k)
- Gama Pharmed Solutions Limited
£24.6k - Industry AVG
Efficiency
resulting in sales per employee of £1.1m, this is more efficient (£43.2k)
- Gama Pharmed Solutions Limited
£43.2k - Industry AVG
Debtor Days
it gets paid by customers after 147 days, this is later than average (22 days)
- Gama Pharmed Solutions Limited
22 days - Industry AVG
Creditor Days
its suppliers are paid after 9 days, this is quicker than average (18 days)
- Gama Pharmed Solutions Limited
18 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Gama Pharmed Solutions Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Gama Pharmed Solutions Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 5.7%, this is a lower level of debt than the average (21.7%)
5.7% - Gama Pharmed Solutions Limited
21.7% - Industry AVG
GAMA PHARMED SOLUTIONS LIMITED financials
Gama Pharmed Solutions Limited's latest turnover from March 2023 is estimated at £1.1 million and the company has net assets of £403.2 thousand. According to their latest financial statements, Gama Pharmed Solutions Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Oct 2016 | Oct 2015 | Oct 2014 | Oct 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||
| Other Income Or Grants | |||||||||||
| Cost Of Sales | |||||||||||
| Gross Profit | |||||||||||
| Admin Expenses | |||||||||||
| Operating Profit | |||||||||||
| Interest Payable | |||||||||||
| Interest Receivable | |||||||||||
| Pre-Tax Profit | |||||||||||
| Tax | |||||||||||
| Profit After Tax | |||||||||||
| Dividends Paid | |||||||||||
| Retained Profit | |||||||||||
| Employee Costs | |||||||||||
| Number Of Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Oct 2016 | Oct 2015 | Oct 2014 | Oct 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 215 | 328 | 441 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 215 | 328 | 441 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 425,428 | 408,875 | 370,010 | 357,012 | 284,196 | 262,411 | 229,895 | 24,000 | 4,800 | 6,000 | 36,975 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 1,805 | 2,221 | 2,212 | 1,405 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 258,173 | 187,047 | 22,512 | 104,092 |
| misc current assets | 0 | 0 | 0 | 0 | 1,282 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 427,233 | 411,096 | 372,222 | 358,417 | 285,478 | 262,411 | 229,895 | 282,173 | 191,847 | 28,512 | 141,067 |
| total assets | 427,448 | 411,424 | 372,663 | 358,417 | 285,478 | 262,411 | 229,895 | 282,173 | 191,847 | 28,512 | 141,067 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 22,369 | 36,749 | 46,304 | 61,391 | 44,788 | 30,732 | 18,214 | 63,255 | 56,565 | 16,361 | 130,975 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 22,369 | 36,749 | 46,304 | 61,391 | 44,788 | 30,732 | 18,214 | 63,255 | 56,565 | 16,361 | 130,975 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 1,830 | 1,830 | 1,400 | 1,400 | 1,680 | 1,400 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 1,830 | 1,830 | 1,400 | 1,400 | 1,680 | 1,400 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 24,199 | 38,579 | 47,704 | 62,791 | 46,468 | 32,132 | 18,214 | 63,255 | 56,565 | 16,361 | 130,975 |
| net assets | 403,249 | 372,845 | 324,959 | 295,626 | 239,010 | 230,279 | 211,681 | 218,918 | 135,282 | 12,151 | 10,092 |
| total shareholders funds | 403,249 | 372,845 | 324,959 | 295,626 | 239,010 | 230,279 | 211,681 | 218,918 | 135,282 | 12,151 | 10,092 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Oct 2016 | Oct 2015 | Oct 2014 | Oct 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||
| Operating Profit | |||||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Tax | |||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 16,137 | 38,874 | 13,805 | 74,221 | 21,785 | 32,516 | 205,895 | 19,200 | -1,200 | -30,975 | 36,975 |
| Creditors | -14,380 | -9,555 | -15,087 | 16,603 | 14,056 | 12,518 | -45,041 | 6,690 | 40,204 | -114,614 | 130,975 |
| Accruals and Deferred Income | 0 | 430 | 0 | -280 | 280 | 1,400 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||||
| Investing Activities | |||||||||||
| capital expenditure | |||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||
| Financing Activities | |||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||
| interest | |||||||||||
| cash flow from financing | |||||||||||
| cash and cash equivalents | |||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | -258,173 | 71,126 | 164,535 | -81,580 | 104,092 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | -258,173 | 71,126 | 164,535 | -81,580 | 104,092 |
gama pharmed solutions limited Credit Report and Business Information
Gama Pharmed Solutions Limited Competitor Analysis
Perform a competitor analysis for gama pharmed solutions limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
gama pharmed solutions limited Ownership
GAMA PHARMED SOLUTIONS LIMITED group structure
Gama Pharmed Solutions Limited has no subsidiary companies.
Ultimate parent company
GAMA PHARMED SOLUTIONS LIMITED
08203789
gama pharmed solutions limited directors
Gama Pharmed Solutions Limited currently has 1 director, Dr Joubert Gama serving since Sep 2012.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Joubert Gama | United Kingdom | 65 years | Sep 2012 | - | Director |
P&L
March 2023turnover
1.1m
+4%
operating profit
37.5k
0%
gross margin
20.6%
+0.71%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
403.2k
+0.08%
total assets
427.4k
+0.04%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
gama pharmed solutions limited company details
company number
08203789
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
September 2012
age
12
accounts
Micro-Entity Accounts
ultimate parent company
previous names
N/A
incorporated
UK
address
c/o flb accountants llp, 1010 eskdale road, wokingham, RG41 5TS
last accounts submitted
March 2023
gama pharmed solutions limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to gama pharmed solutions limited.
gama pharmed solutions limited Companies House Filings - See Documents
| date | description | view/download |
|---|
